B.S., State University of New York at Brockport, Biological Sciences
M.S., University of Rochester, Genetics
Ph.D., University of Rochester, Biomedical Genetics
Research Interests: The overall goal of my research is to investigate mechanisms controlling the proliferation of mammalian cells, and how disruption of these processes alters normal tissue function and contributes to human disease. My work is focused on identifying targetable pathways controlling the initiation and maintenance of pediatric and adult neuroendocrine tumors.
B.S., University of Ioannina, Greece, Biological Applications and Technologies
M.Sc., University of Ioannina, Greece, Clinical Biochemistry and Immunochemistry – Microbial Biotechnology
Ph.D., European Molecular Biology Laboratory and University of Heidelberg, Germany, Joint Program, Molecular Biology
Research Interest: I am interested in investigating mechanisms of cancer progression by tumor suppression as well as identifying cancer vulnerabilities by applying genome-wide/targeted CRISPR screens.
B.S., University of California, Los Angeles, Bioengineering
Ph.D., Stanford University, Bioengineering
Research Interest: I am interested in studying alterations in signaling pathways in cancer cells and developing novel therapeutic strategies.
Joint appointment with lab of Edward Graves
B.S., Kyoto University Graduate School of Medicine, Japan
M.D., Kyoto University Graduate School of Medicine, Japan, Medicine
Ph.D., Kyoto University Graduate School of Medicine, Japan, Radiation Oncology and Image-applied Therapy
Research Interest: I’m interested in how radiotherapy affects immune cells in the tumor microenvironment and how to overcome the radioresistance of tumors.
B.S., Peking University, China, Biological Sciences
Ph.D., Duke University, Cell Biology
Research Interest: Cellular and molecular mechanisms of small cell lung cancer progression and metastases.
B.S., University of California, Los Angeles, Molecular, Cell, and Developmental Biology
Research Interests: I am interested in studying the mechanisms that regulate basic cellular processes, such as the cell cycle, proliferation, and metabolism, under different pathological and physiological conditions.
B.A., University of California, Berkeley, Molecular and Cell Biology & Psychology
Research Interests: I’m interested in uncovering the networks of non-oncogene addiction in Small Cell Lung Cancer in order to guide the first successful targeted therapies against this incredibly lethal cancer.
B.A., Harvard University, Molecular and Cellular Biology
Research Interests: I am interested in the links between cell cycle regulation and pluripotency in embryonic stem cells; in the properties shared between embryonic stem cells and cancer cells; and in the non-canonical roles of the Rb/E2F pathway in early embryonic development.
Yan Ting Shue
B.S., Nanyang Technological University, Singapore, (with Honors, Biological Sciences)
Research Interests: I am currently studying epigenetic mechanisms in small cell lung cancer.
B.S., Texas A&M, Biochemistry
Research Interests: Since learning about organelles in seventh grade I fell in love with cell biology. I feel fortunate to have a rewarding career studying the protein pathways of disease, which had included analysis of the proteins involved in pigment formation, antibody drug therapy, and how certain drug treatments affect small cell lung cancer.
Visiting Student Researchers
B.S., University of Heidelberg, Germany
M.D. candidate (ongoing), University of Heidelberg, Germany
Research Interests: During medical school, I developed a major interest in the mechanisms and signaling pathways in oncogenesis, especially in the consequences of cell cycle dysregulation.
B.S. (ongoing), California State University, Fullerton, Biochemistry
Research Interests: I am interested in using multidisciplinary approaches to understand the inherent differences between physiological and pathological biological systems. I aim to study how molecular abnormalities can affect protein function, cell signaling, and regulation of survival / differentiation.
Laurent Le Cam, PhD
Dr. Laurent Le Cam is serving as head of the Molecular Oncogenesis group at the Institut de Recherche en Cancérologie de Montpellier in France. He received his Ph.D. from Montpellier University in 1999, trained as a post-doc at the Dana Farber Cancer Institute in Pr. Sicinski’s lab until 2003 and set up his own research group at Montpellier Cancer Center in France in 2008. His ongoing projects relate to the understanding of molecular circuitries and metabolic networks that are deregulated during cancer progression, and more specifically those regulated by different components of the p53 tumor suppressor pathway.